228 related articles for article (PubMed ID: 24892849)
21. Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
Shang W; Feng G; Sun R; Wang X; Liu W; Zhang S; Li J; Pang X; Wang Y; Zhang W
J Clin Pharm Ther; 2012 Dec; 37(6):652-6. PubMed ID: 22725946
[TBL] [Abstract][Full Text] [Related]
22. Safety of micafungin in pediatric clinical trials.
Arrieta AC; Maddison P; Groll AH
Pediatr Infect Dis J; 2011 Jun; 30(6):e97-e102. PubMed ID: 21378595
[TBL] [Abstract][Full Text] [Related]
23. Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study.
Viscoli C; Bassetti M; Castagnola E; Cesaro S; Menichetti F; Ratto S; Tascini C; Giacobbe DR
BMC Infect Dis; 2014 Dec; 14():725. PubMed ID: 25551699
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis.
Maximova N; Schillani G; Simeone R; Maestro A; Zanon D
Adv Ther; 2017 May; 34(5):1184-1199. PubMed ID: 28429246
[TBL] [Abstract][Full Text] [Related]
25. [Micafungin for therapy of invasive candidiasis in solid organ transplant recipients].
Fortún-Abete J
Rev Iberoam Micol; 2009 Mar; 26(1):65-8. PubMed ID: 19463280
[TBL] [Abstract][Full Text] [Related]
26. [Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?].
Salavert M; Jarque I
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():43-9. PubMed ID: 21420577
[TBL] [Abstract][Full Text] [Related]
27. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.
Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A;
Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis associated with micafungin use in a preterm infant.
King KY; Edwards MS; Word BM
J Perinatol; 2009 Apr; 29(4):320-2. PubMed ID: 19325554
[TBL] [Abstract][Full Text] [Related]
29. Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.
Mehta PA; Vinks AA; Filipovich A; Bleesing J; Jodele S; Jordan MB; Marsh R; Tarin R; Edwards S; Fearing D; Lawrence J; Davies SM
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1458-62. PubMed ID: 20546908
[TBL] [Abstract][Full Text] [Related]
30. Micafungin - the newest echinocandin.
Temesgen Z; Barreto J; Vento S
Drugs Today (Barc); 2009 Jun; 45(6):469-78. PubMed ID: 19856528
[TBL] [Abstract][Full Text] [Related]
31. Refractory neonatal candidemia and high-dose micafungin pharmacotherapy.
Natarajan G; Lulic-Botica M; Aranda JV
J Perinatol; 2009 Nov; 29(11):738-43. PubMed ID: 19776753
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacodynamics and pharmacokinetics of micafungin in adults, children and neonate].
Catalán-González M; Carlos Montejo-González J
Rev Iberoam Micol; 2009 Mar; 26(1):23-34. PubMed ID: 19463274
[TBL] [Abstract][Full Text] [Related]
33. Safety of high-dose micafungin for patients with hematological diseases.
Yamazaki S; Nakamura F; Yoshimi A; Ichikawa M; Nannya Y; Kurokawa M
Leuk Lymphoma; 2014 Nov; 55(11):2572-6. PubMed ID: 24460099
[TBL] [Abstract][Full Text] [Related]
34. Caspofungin versus micafungin in the incidence of hepatotoxicity in patients with normal to moderate liver failure.
Shibata Y; Hagihara M; Kato H; Kawasumi N; Hirai J; Nishiyama N; Asai N; Koizumi Y; Yamagishi Y; Matsuura K; Mikamo H
J Infect Chemother; 2017 Jun; 23(6):349-353. PubMed ID: 28431933
[TBL] [Abstract][Full Text] [Related]
35. Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.
Huang X; Chen H; Han M; Zou P; Wu D; Lai Y; Huang H; Chen X; Liu T; Zhu H; Wang J; Hu J
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1509-16. PubMed ID: 22469884
[TBL] [Abstract][Full Text] [Related]
36. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
Cross SA; Scott LJ
Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009
[TBL] [Abstract][Full Text] [Related]
37. [Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis].
Montejo M; Quindós G
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():15-22. PubMed ID: 21420572
[TBL] [Abstract][Full Text] [Related]
38. Echinocandins: the newest class of antifungals.
Sucher AJ; Chahine EB; Balcer HE
Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
[TBL] [Abstract][Full Text] [Related]
39. [Differential pharmacokinetic characteristics of micafungin. Experience in special populations].
Grau Cerrato S; Luque Pardos S; Ferrández Quirante O
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():10-4. PubMed ID: 21420571
[TBL] [Abstract][Full Text] [Related]
40. [Liver toxicity of micafungin. Is this drug safe?].
Valerio M; Muñoz P; Bouza E
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():29-32. PubMed ID: 21420574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]